Compositions and methods for regulating production of an antibody like protein and ribonucleic acid
AssigneeWyvern Pharmaceuticals Inc.
InventorBradley G. THOMPSON
Life of this patent
Estimating the term…
Abstract
The present disclosure relates to one or more agents, therapies, treatments, and methods of use of the agents and/or therapies and/or treatments for producing an antibody like protein (ALP) and one or more sequences of miRNA that are complementary to the mRNA of a target, viral-specific protein or proteins. Embodiments of the present disclosure can be used as a therapy or a treatment for a subject that has a condition whereby the production of the APL and decreased production of a target, viral-specific protein or proteins may be of therapeutic benefit.
Claims3
A method of treating a subject with a condition, the method comprising a step of administering to the subject a therapeutic dose of a composition that comprises a recombinant plasmid (RP) with a sequence of nucleotides that comprise a start region, an end region and an insert positioned between the start region and the end region, wherein the insert encodes for production of an antibody-like protein (ALP) that is bindable with a surface protein of an influenza virus and a further sequence of micro-interfering ribonucleic acid (miRNA) that binds to and causes degradation of messenger ribonucleic acid (mRNA) that encodes for a target, viral protein of the influenza virus,
- wherein the sequence of nucleotides of the insert comprises:
- i) a sequence that comprises SEQ ID No:
- 1, and
- ii) the further sequence that comprises SEQ ID No:
- 2.
3-4. (canceled)
Dependencies are inferred from the claim text.